ArticleIJID regions2025
Enterovirus 71 seropositivity among children and adolescents in Bangladesh.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The world has witnessed an increase in non-polio enterovirus infections. This study assessed the seroprevalence of enterovirus 71 (EV71) neutralizing antibodies (NAbs) and explored associated risk factors among children and adolescents in Bangladesh. Methods: Between March 2019 and March 2020, a cross-sectional survey was conducted in one urban and one rural district of Bangladesh. A total of 1207 children aged 0-17 years were enrolled, including 607 from urban and 600 from rural areas. Serum samples were tested using a cytopathic effect-based microneutralization assay to measure EV71 NAb titers. Demographic and socio-epidemiological data were also collected through structured interviews. Results: Overall, 817 (67.7%) were seropositive for EV71, with 68.3% in urban and 31.7% in rural areas. Age-specific seroprevalence in urban vs rural settings was: <6 months, 96.0% vs 38.9%; 6-71 months, 90.3% vs 35.1%; 6-11 years, 92.7% vs 80.4%; 12-17 years, 100% vs 77.6%. In urban areas, having an indoor toilet was linked to lower seropositivity ( Conclusions: The high EV71 seroprevalence in Bangladeshi children indicates widespread exposure. Further research on non-polio enterovirus, including EV71, is needed to inform surveillance, prevention, and potential vaccine strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.